Characterization and Outcomes of Disease Progression in 52 Patients Treated with BRAF-V600 + MEK Inhibitors for Advanced Melanoma.
Dermatology
; 234(3-4): 92-98, 2018.
Article
en En
| MEDLINE
| ID: mdl-30110681
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Piperidinas
/
Neoplasias Cutáneas
/
Azetidinas
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Vemurafenib
/
Melanoma
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Límite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2018
Tipo del documento:
Article